832 related articles for article (PubMed ID: 16449325)
1. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance.
Nguyen T; Bjorkman J; Paton BC; Crane DI
J Cell Sci; 2006 Feb; 119(Pt 4):636-45. PubMed ID: 16449325
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division.
Itoyama A; Honsho M; Abe Y; Moser A; Yoshida Y; Fujiki Y
J Cell Sci; 2012 Feb; 125(Pt 3):589-602. PubMed ID: 22389399
[TBL] [Abstract][Full Text] [Related]
3. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis disorder patients.
Maxwell MA; Allen T; Solly PB; Svingen T; Paton BC; Crane DI
Hum Mutat; 2002 Nov; 20(5):342-51. PubMed ID: 12402331
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome elongation and constriction but not fission can occur independently of dynamin-like protein 1.
Koch A; Schneider G; Lüers GH; Schrader M
J Cell Sci; 2004 Aug; 117(Pt 17):3995-4006. PubMed ID: 15286177
[TBL] [Abstract][Full Text] [Related]
5. Aberrant peroxisome morphology in peroxisomal beta-oxidation enzyme deficiencies.
Funato M; Shimozawa N; Nagase T; Takemoto Y; Suzuki Y; Imamura Y; Matsumoto T; Tsukamoto T; Kojidani T; Osumi T; Fukao T; Kondo N
Brain Dev; 2006 Jun; 28(5):287-92. PubMed ID: 16376506
[TBL] [Abstract][Full Text] [Related]
6. Fis1, DLP1, and Pex11p coordinately regulate peroxisome morphogenesis.
Kobayashi S; Tanaka A; Fujiki Y
Exp Cell Res; 2007 May; 313(8):1675-86. PubMed ID: 17408615
[TBL] [Abstract][Full Text] [Related]
7. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders.
Reuber BE; Germain-Lee E; Collins CS; Morrell JC; Ameritunga R; Moser HW; Valle D; Gould SJ
Nat Genet; 1997 Dec; 17(4):445-8. PubMed ID: 9398847
[TBL] [Abstract][Full Text] [Related]
8. A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11β gene.
Ebberink MS; Koster J; Visser G; Spronsen Fv; Stolte-Dijkstra I; Smit GP; Fock JM; Kemp S; Wanders RJ; Waterham HR
J Med Genet; 2012 May; 49(5):307-13. PubMed ID: 22581968
[TBL] [Abstract][Full Text] [Related]
9. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.
Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G
Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.
Wei H; Kemp S; McGuinness MC; Moser AB; Smith KD
Ann Neurol; 2000 Mar; 47(3):286-96. PubMed ID: 10716247
[TBL] [Abstract][Full Text] [Related]
11. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1.
Imamura A; Shimozawa N; Suzuki Y; Zhang Z; Tsukamoto T; Fujiki Y; Orii T; Osumi T; Wanders RJ; Kondo N
Pediatr Res; 2000 Oct; 48(4):541-5. PubMed ID: 11004248
[TBL] [Abstract][Full Text] [Related]
12. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders.
Crane DI; Maxwell MA; Paton BC
Hum Mutat; 2005 Sep; 26(3):167-75. PubMed ID: 16086329
[TBL] [Abstract][Full Text] [Related]
13. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism.
Gootjes J; Schmohl F; Mooijer PA; Dekker C; Mandel H; Topcu M; Huemer M; Von Schütz M; Marquardt T; Smeitink JA; Waterham HR; Wanders RJ
Hum Mutat; 2004 Aug; 24(2):130-9. PubMed ID: 15241794
[TBL] [Abstract][Full Text] [Related]
14. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes.
Matsumoto N; Tamura S; Fujiki Y
Nat Cell Biol; 2003 May; 5(5):454-60. PubMed ID: 12717447
[TBL] [Abstract][Full Text] [Related]
15. Pex13, the mouse ortholog of the human peroxisome biogenesis disorder PEX13 gene: gene structure, tissue expression, and localization of the protein to peroxisomes.
Björkman J; Gould SJ; Crane DI
Genomics; 2002 Feb; 79(2):162-8. PubMed ID: 11829486
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations.
Rosewich H; Ohlenbusch A; Gärtner J
J Med Genet; 2005 Sep; 42(9):e58. PubMed ID: 16141001
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in PEX5-deficient peroxisome biogenesis defective cell lines.
Ebberink MS; Mooyer PA; Koster J; Dekker CJ; Eyskens FJ; Dionisi-Vici C; Clayton PT; Barth PG; Wanders RJ; Waterham HR
Hum Mutat; 2009 Jan; 30(1):93-8. PubMed ID: 18712838
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients.
Shimozawa N; Zhang Z; Suzuki Y; Imamura A; Tsukamoto T; Osumi T; Fujiki Y; Orii T; Barth PG; Wanders RJ; Kondo N
Biochem Biophys Res Commun; 1999 Aug; 262(2):504-8. PubMed ID: 10462504
[TBL] [Abstract][Full Text] [Related]
19. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y
Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004
[TBL] [Abstract][Full Text] [Related]
20. A lethal defect of mitochondrial and peroxisomal fission.
Waterham HR; Koster J; van Roermund CW; Mooyer PA; Wanders RJ; Leonard JV
N Engl J Med; 2007 Apr; 356(17):1736-41. PubMed ID: 17460227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
